Cite
Di Meo A, Miller JJ, Fabros A, et al. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response. J Appl Lab Med. 2022;7(1):57-65doi: 10.1093/jalm/jfab087.
Di Meo, A., Miller, J. J., Fabros, A., Brinc, D., Hall, V., Pinzon, N., Ierullo, M., Ku, T., Ferreira, V. H., Kumar, D., Pasic, M. D., & Kulasingam, V. (2022). Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response. The journal of applied laboratory medicine, 7(1), 57-65. https://doi.org/10.1093/jalm/jfab087
Di Meo, Ashley, et al. "Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response." The journal of applied laboratory medicine vol. 7,1 (2022): 57-65. doi: https://doi.org/10.1093/jalm/jfab087
Di Meo A, Miller JJ, Fabros A, Brinc D, Hall V, Pinzon N, Ierullo M, Ku T, Ferreira VH, Kumar D, Pasic MD, Kulasingam V. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response. J Appl Lab Med. 2022 Jan 05;7(1):57-65. doi: 10.1093/jalm/jfab087. PMID: 34342347; PMCID: PMC8436397.
Copy
Download .nbib